Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion type Assertion NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_head.
- NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion description "[Furthermore, SERS was preclinically utilized to test EGFR mutation status in MPE samples from 35 patients with lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_provenance.
- NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion evidence source_evidence_literature NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_provenance.
- NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion SIO_000772 25495142 NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_provenance.
- NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion wasDerivedFrom befree-2016 NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_provenance.
- NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_assertion wasGeneratedBy ECO_0000203 NP1246817.RAOXVuM0TL1yf5TaN_Uc3lca9SzzVnVrUzCO1ok9Gwoy8130_provenance.